Abstract |
Pulmonary embolism is the third cause of mortality by cardiovascular disease after coronary artery disease and stroke, and its incidence is around 1/1000 per year. During the last two decades, many different non-invasive diagnostic tests have been developed and validated. For hemodynamically stable outpatients, the diagnosis of acute pulmonary embolism mainly rests on the sequential use of clinical assessment, D-dimer measurement and multidetector CT. In patients with a contraindication to CT, lower limb venous ultrasonography and ventilation-perfusion scintigraphy remain valid options. Massive pulmonary embolism is a distinct clinical entity with a specific diagnostic approach. In unstable patients with suspected pulmonary embolism, echocardiography should be the initial test.
|
Authors | Marc Righini, Helia Robert-Ebadi, Grégoire Le Gal |
Journal | Presse medicale (Paris, France : 1983)
(Presse Med)
Vol. 44
Issue 12 Pt 2
Pg. e385-91
(Dec 2015)
ISSN: 2213-0276 [Electronic] France |
PMID | 26585743
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2015 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Fibrin Fibrinogen Degradation Products
- fibrin fragment D
|
Topics |
- Echocardiography
(methods)
- Fibrin Fibrinogen Degradation Products
(analysis)
- Humans
- Multidetector Computed Tomography
(methods)
- Protein Multimerization
- Pulmonary Embolism
(diagnosis, diagnostic imaging)
- Radionuclide Imaging
- Venous Thrombosis
(diagnostic imaging)
- Ventilation-Perfusion Ratio
|